老挝全球药房Laos Global Pharmacy
Carrying forward a five-thousand-year legacy, safeguarding modern health
维奈克拉是全球首个获批上市的高选择性BCL-2小分子靶向抑制剂,也是首个以 “细胞凋亡通路” 为核心机制的血液肿瘤治疗药物。
所有称呼维奈托克、Venetoclax、唯可来、Venclexta、LuciVenet
Copyright 2024 @ haiouhealth.com All right reserved SEAGULL HEALTH
Order on WhatsApp